Skip to main content

DSwiss Inc

corporate_fare Company Profile

DSwiss Inc

DQWS·OTC·Industrial Applications And Services·CIK 0001652561

DSwiss, Inc. is a Nevada corporation incorporated on May 28, 2015, primarily engaged in the supply of high-quality health and beauty products. The company operates through its wholly-owned subsidiary, DSwiss Holding Limited, incorporated in Seychelles. Its product offerings include weight management beverages, anti-aging solutions, and immune system enhancers. Operations are conducted through DSwiss Sdn Bhd, a private limited liability company incorporated in Malaysia. DSwiss Holding Limited owns 100% equity interest in DSwiss (HK) Limited, a Hong Kong entity, which in turn holds 100% equity interest in DSwiss Sdn Bhd. DSwiss (HK) Limited also acquired the remaining 60% equity interest in DSwiss Biotech Sdn Bhd for RM1 on January 18, 2023, making it a wholly-owned subsidiary. DSwiss Biotech Sdn Bhd, incorporated in Malaysia on March 17, 2016, focuses on research and development on biotechnology. DSwiss (HK) Limited, incorporated in Hong Kong on May 28, 2015, engages in international trade in health care and beauty products. DSwiss Sdn Bhd, incorporated in Malaysia on March 10, 2011, supplies health care products. The company focuses on premium beauty and health products, operating as a biotech nutraceutical firm and a Private Label ODM/OEM provider specializing in healthcare, skincare, and personal care solutions.

DSwiss Inc (OTC:DQWS) is a publicly traded company in the Industrial Applications And Services sector. Wiseek monitors DQWS SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.

Recent high-impact activity:

  • DSwiss Inc Reports Q1 2026 Results: Revenue Halves, Going Concern Warning Persists, 12-Month Cash Runway
  • DSwiss Inc Reports Going Concern Doubt, Material Weaknesses, and Shift to Net Loss in 2025 Annual Report

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$2.92M
Net Income
-$76.86K
Diluted EPS
-$0.00
Op. Cash Flow
-$94.3K
Free Cash Flow
-$135.33K
Gross Profit
$564.56K
Operating Income
-$1.17K
Cash & Equivalents
$285.03K
Debt / Equity
0.00×
Net Margin
-2.6%
Shares Outstanding
206.9M sh
Source: 10-K · filed 2026-03-31 · accession 0001493152-26-013865
Browse all tickers starting with D →
$0.0424
52-week range · as of 2026-05-15 $0.0031 – $11
Market cap
$8.77M
Volume
10K (3.5× avg)
3-mo avg 2.9K
Live data · 2026-06-14 05:16 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed DQWS - Latest Insights

DQWS
May 15, 2026, 6:07 AM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $0.0424
Real-time Price: $0.0424 info
Change: $0 (0%) info
Market Cap: $8.773M info
DQWS
Mar 31, 2026, 9:02 AM EDT
Filing Type: 10-K
Importance Score:
9
Price at Filing: $0.0845
Real-time Price: $0.0424 info
Change: -$0.0421 (-50%) info
Market Cap: $8.773M info